- Home
- OCGN vs EIC Comparison
OCGN vs EIC Comparison
Compare OCGN & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- EIC
- Stock Information
- Founded
- OCGN 2013
- EIC N/A
- Country
- OCGN United States
- EIC United States
- Employees
- OCGN N/A
- EIC N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- EIC Finance/Investors Services
- Sector
- OCGN Health Care
- EIC Finance
- Exchange
- OCGN Nasdaq
- EIC Nasdaq
- Market Cap
- OCGN 246.8M
- EIC 287.1M
- IPO Year
- OCGN N/A
- EIC 2019
- Fundamental
- Price
- OCGN $0.89
- EIC $15.99
- Analyst Decision
- OCGN Strong Buy
- EIC
- Analyst Count
- OCGN 3
- EIC 0
- Target Price
- OCGN $5.67
- EIC N/A
- AVG Volume (30 Days)
- OCGN 6.1M
- EIC 116.0K
- Earning Date
- OCGN 11-08-2024
- EIC 11-14-2023
- Dividend Yield
- OCGN N/A
- EIC 13.63%
- EPS Growth
- OCGN N/A
- EIC N/A
- EPS
- OCGN N/A
- EIC 0.80
- Revenue
- OCGN $4,700,000.00
- EIC N/A
- Revenue This Year
- OCGN N/A
- EIC N/A
- Revenue Next Year
- OCGN N/A
- EIC N/A
- P/E Ratio
- OCGN N/A
- EIC $20.31
- Revenue Growth
- OCGN N/A
- EIC N/A
- 52 Week Low
- OCGN $0.49
- EIC $13.00
- 52 Week High
- OCGN $2.11
- EIC $16.48
- Technical
- Relative Strength Index (RSI)
- OCGN 54.92
- EIC 65.84
- Support Level
- OCGN $0.79
- EIC $15.30
- Resistance Level
- OCGN $0.88
- EIC $15.43
- Average True Range (ATR)
- OCGN 0.08
- EIC 0.17
- MACD
- OCGN 0.01
- EIC 0.07
- Stochastic Oscillator
- OCGN 65.97
- EIC 95.11
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.